Status:
NOT_YET_RECRUITING
Genomic Profiling of Pancreatic Cystic Tumors
Lead Sponsor:
Samsung Medical Center
Conditions:
Pancreatic Cyst
Eligibility:
All Genders
19+ years
Brief Summary
This study aims to find out whether quantitative and qualitative analysis, including genetic mutation analysis, of samples obtained from patients with pancreatic cysts is associated with the risk of m...
Detailed Description
Pancreatic cysts, especially mucinous cysts, are precancerous lesions that can cause pancreatic cancer, and follow-up surveillance is important. However, there is a lack of clear medical evidence for ...
Eligibility Criteria
Inclusion
- Pancreatic cyst patients undergoing cyst aspiration or biopsy or surgical resection
- Patients who gave written informed consent
Exclusion
- Anyone who has not signed a written consent form.
- Patients deemed unsuitable for research (severe infection, drug abuse, severe mental illness, etc.)
Key Trial Info
Start Date :
January 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2030
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06195904
Start Date
January 15 2024
End Date
May 15 2030
Last Update
January 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351
2
Seoul St. Mary's Hospital
Seoul, South Korea, 06591